Market Analytics Group (MAG) Schedules its Appearance at the Upcoming Pharmaceutical Management Science Association (PMSA)

Market Analytics Group (MAG) schedules its appearance at the upcoming Pharmaceutical Management Science Association (PMSA).

Coral Gables, FL (PRWEB) April 27, 2006 -- Market Analytics Group (MAG) schedules its appearance at the upcoming Pharmaceutical Management Science Association (PMSA) Trade Show in Hilton Head, SC. Team members from MAG will be available to demonstrate their expertise in secondary marketing analytics to industry participants on Monday, May 22nd.

This year, President Katherine Cooley and her team plan to showcase Market Analytic Group’s superior expertise in forecasting, specific to the pharmaceutical and industry.

Visit www.imagnified.com for a full detail of services.

Market Analytics Group would like to invite you to schedule your capabilities presentation either by phone or in person.

For additional information, contact: Fatma Aybegum Yavuz at 305-728-7110

About Market Analytics Group
Market Analytics Group, headquartered in Coral Gables, FL, is a premier Pharmaceuticals Marketing and Sales Management Consultancy Company. The company is the first and only Pharmaceuticals Marketing/Management Science Consultancy in Miami-Dade/South Florida founded by a collective of former pharmaceuticals insiders and leading industry consultants. Since its early days, Market Analytics Group has been assisting the world’s largest and smallest pharmaceutical and biotech entities with customized solutions to analytical marketing and sales challenges.

About Pharmaceutical Marketing Research Group
The Pharmaceutical Marketing Research Group (PMRG), was founded in 1961 and is the oldest association of its kind. PMRG is an independent, voluntary, non-profit association whose purpose is to stimulate improvement of marketing research and its utilization. This overall purpose will be executed by educational activities directed toward (a) better understanding of the role of marketing research; (b) demonstrating how marketing research can shape & influence business decisions; (c) developing & evaluating marketing research techniques; (d) establishing, maintaining & improving professional marketing research standards; & (e) providing regular educational forums to develop & maintain professional competency & to identify, discuss & analyze current issues of critical importance.

Contact Information:
Fatma Aybegum Yavuz
Vice President
Market Analytics Group
2332 Galiano St.SUITE 309
Coral Gables, FL 33134
Phone (305) 728-7110
Fax (305) 728-7111
Visit Us Online
www.imagnified.com

###

Press Contact: Fatma Yavuz
Company Name: MARKET ANALYTICS GROUP
Email: email protected from spam bots
Phone: 305-728-7110
Website: www.imagnified.com

¶ 9:47 AM 0 comments

Controversy Contines Over Safety of Mifeprex, Abortion Pill

After several deaths allegedly linked to Mifeprex, federal regulators are still investigating the safety of the RU-486 abortion pill

New York, NY (PRWEB) April 26, 2006 -- Since Mifeprex’s approval in 2000, the drug has been linked to several deaths of women who died of Sepsis or severe bacterial infection. Despite these risks, the drug continues to be offered nationwide by doctors as an alternative to surgical abortions.

Mifeprex (mifepristone), “the abortion pill”, with a 92% success rate, can induce abortions up to seven weeks after fertilization. To date, there have been 637 reported cases of adverse side effects associated with Mifeprex. Many of these cases involved side effects such as hemorrhage, infection, and deadly sepsis or septic shock. There have been five reported deaths from septic shock after taking Mifeprex. All the deaths have been associated with a rare bacterial infection called Clostridium sordellii.

Federal regulators are currently investigating these deaths and the risks of Mifeprex, but the abortion drug is not the only related controversy in the news. The Pro-Life and Pro-Choice debate continues as South Dakota recently banned all forms of abortion while Massachusetts and Illinois ruled to make Plan-B emergency contraceptives available at all pharmacies.

To learn more about Mifeprex Abortion Pill side effects visit LawyersandSettlements.com: http://www,lawyersandsettlements.com/case/abortion_pill?ref=pr

About Online Legal Marketing:
LawyersandSettlements.com offers a comprehensive website with up-to-date legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can receive free case evaluations.

Visit us at:
www,lawyersandsettlements.com/

Contact us at:
604-608-3435

Press Contact: Scott Wurtele
Company Name: ONLINE LEGAL MARKETING LTD.
Phone: 604-608-3435
Website: http:/www.lawyersandsettlements.com/case/abortion_pill

¶ 9:32 PM 0 comments

SmartChoiceDrugStore Announces Wholesale Prescription Drug Plan

Austin, Texas based discount pharmacy launches wholesale prescription drug club in which prescription drugs are sold at wholesale prices. This program benefits millions of US citizens and business owners who cannot afford prescription drug coverage. Call 866-BUY-MEDS for further information, price quotes, or to sign up.

Austin, TX (PRWEB) April 26, 2006 -- SmartChoiceDrugStore (SCD) implements an unparalleled wholesale pricing model, which is completely new for the retail pharmacy industry. The new wholesale pricing model is offered through the SCD Wholesale Club and is priced substantially lower than any other discount, prescription drug program as a way to meet the demands of the underinsured, uninsured and businesses who continue to be devastated by the skyrocketing cost of prescription drugs. No other United States based pharmacy offers the type of savings that are available through the wholesale prescription club. For more information please call 866-BUY-MEDS.

The retail pharmacy industry and pharmacy discount cards have yet to address the rising costs of prescription drugs and even Medicare Part D does not address all uninsured citizens. In addition, the Canadian pharmacy response to the high costs of prescription drugs cannot address drug costs once they are generic. Therefore, SCD believed it was necessary to implement a new, wholesale pricing schedule for those citizens who cannot afford the astronomical costs of prescription drugs from retail pharmacies.

SCD CEO, Chatrick Clark, says that SCD Wholesale Club’s pricing is substantially lower than any retail pharmacy has offered before. “We are addressing the prescription drug needs of an enormous segment of the population that has been left to fend for themselves. The need for low cost medications has become critical in this nation and our belief is that the SCD Wholesale Club business and pricing model can address this need head on. It’s a win-win situation for both the customer and SCD,” Clark says.

The SCD Wholesale Club also offers business owners the ability to offer prescription benefits to their employees that they could not usually afford either through insurance or supplemental health coverage. While SCD Wholesale club is not insurance, it does offer business owners a way of assisting their employees in obtaining an affordable way to meet their prescription drug needs. The Club makes it possible for employers to offer prescription benefits to their employees at costs that their employees cannot obtain independently. The Club extends this offer to the employee’s family as well. Costs for the Club via the business plan run $60 a year for one employee.

SCD also maintains a discount pharmacy through its web site www.smartchoicedrugstore.com. SCD’s web site does offer substantially discounted pricing when the Club is not the best fit for an individual. “This usually comes about when a customer is in the need of a single, non-recurring prescription like antibiotics and is not on a maintenance medication. In that case, our normal discount pricing is the best fit and is still far less in cost than visiting your local pharmacy,” Clark says.

Currently, club prices, information, and sign-up are done via toll free number at 866-289-6337. The SCD Wholesale Club will be available by mid-May on the SmartChoiceDrugStore web site.

Media packets and information are available by calling Sara Wilkinson at 866-289-6337 ext 102. Texas pharmacy license #24171.


Press Contact: Chatrick Clark
Company Name: SCDRUGSTORE, INC.
Phone: 8662896337
Website: www.smartchoicedrugstore.com

¶ 12:20 PM 0 comments

Head Off the Pain

"Not tonight, dear, I have a headache." Those words have become the universal stop sign for bedroom romance. Sometimes it’s not true but many times headaches can just stop you in your tracks. The “new” Sinol Nasal Spray for headaches is here and it really works.

Newtown, CT (PRWEB) April 25, 2006 -- There are nearly 28 million headache sufferers in the United States 12 years or older. This means one in every four U.S. households has a migraine sufferer. More than half of these sufferers have never received a physician diagnosis and most are not receiving appropriate treatment, despite new and effective therapies designed specifically to treat the pain and symptoms of migraine. There have been no dramatic changes in the way physicians approach the treatment of migraine in the last ten years. Twenty-four percent of migraine sufferers report headaches so severe that they have sought emergency room care.

There is good news for those chronic sufferers, there’s a new nasal spray in town and it works quickly. Sinol Nasal Spray for headaches is all natural and is made from the pepper. Sinol is the first OTC nasal spray for chronic headaches and there is nothing else like it. The pepper in Sinol is called “capsaicin” which is clinically proven to reduce pain, swelling and quickly relieves migraines and cluster headaches.

“Our Sinol nasal spray for headaches has been an unbelievable break through,” said Paul Carpenter, President of Sinol USA, Inc. located in Sandy Hook, CT. Carpenter came across capsaicin when his cousin told him that their grandfather used cayenne pepper on top of a shot of bourbon to relive his symptoms. After a few years of research and working with EMS Labs, a FDA licensed laboratory in Pennsylvania, the perfect formula was born. “It took us many formulations to create what we have today,” Carpenter said. “We have a group of physicians and pharmacists that are using Sinol in private practices all over the country with outstanding results.”

“Some people experience premigraine warning symptoms, including blurred vision, "floating" visual images, and numbness in an arm or leg. Our Sinol Nasal Spray works very quickly and headache customers are telling us it relieves their headache pain before it can get to a full blown problem. As anyone with a migraine can attest, migraines are almost always accompanied by nausea- sometimes severe nausea- and vomiting. Taking any medication by mouth is often impossible. That's why so many of the prescription medications come in injections and nasal sprays. The onset of action is much faster with a nasal spray than for an oral medication, AND there is the great advantage of patients being able to administer Sinol without having to swallow it and keep it down,” Carpenter stated.

Columbia University College of Physicians & Surgeons in New York City has proven that Intranasal medications for the treatment of headaches are significantly more effective than by digestive means. In an “Open Label Safety Assessment” performed last October, Sinol Nasal Spray was 85% effective in relieving headache sufferers and 90% in relieving allergy symptoms.
“I am very glad that we are able to assist people with an all natural product that works extremely well. Antibiotic resistance is a HUGE issue in medicine right now in America and around the world. The more we use antibiotics in people and animals, the more resistant bacteria is becoming,” Carpenter said.

About Sinol USA, Inc.
Sinol USA, Inc. is changing the way consumers think about health care and their well-being. Sinol is a high growth, “all natural” and over-the-counter health care company engaged in the development and marketing of products that utilize old-fashioned yet unique methods to relieve chronic health care problems. For more information, please visit http://www.sinolusa.com

###

Press Contact: Paul Carpenter
Company Name: SINOL USA INC
Email: email protected from spam bots
Phone: 1-800-632-2824
Website: www.sinolusa.com

¶ 8:23 AM 0 comments

Suncombe Micro-Mixes Small Volumes

Suncombe introduce ‘Micro-Mixing’ to their range of Bio/Pharma vessels. Designed to provide a solution for mixing of low volumes of product, the new technology has undergone extensive development and trials prior to release.

London, UK (PRWEB) April 22, 2006 -- Suncombe Ltd, the UK based cleaning and hygienic processing company, launch a new generation of Biotech and Pharmaceutical Vessels incorporating our ‘Micro-Mixing’ technology. Designed to offer a solution to aseptic mixing of small volumes, the new technology was developed in response to client requests for this facility.

Integrated into the PharmaVessel range, the innovative ‘Micro-mixing’ technology is able to mix volumes from a few litres to 100’s of litres.

Originally launched in 1961, Suncombe PharmaVessels, have been constantly updated to incorporate new technology and comply with current standards.

Used in the biotech, healthcare, diagnostics, parenterals and pharmaceutical sectors, the vessels are available in standard versions or bespoke versions to suit your requirements.

Steve Overton, Suncombes Operation Director declares “The new technology is very exciting for us, adding a new dimension to low volume processing. We have worked on this for many years and are very pleased to have developed a solution”.

The new ‘Micro-Mix’ vessels include the simple validation package which is a feature on all of our products, and include comprehensive databooks, processes, procedures and documentation.

The CE marked vessel are constructed from 316L stainless steel, include certified surface finishes and are available as atmospheric or PD5500/ASME pressure vessels.

Options are available for jackets, insulation, ATEX versions, SIP duties, skid mounted units and control systems.

Designed and manufactured in the UK by Suncombe personnel, our experienced engineers are available to discuss any requirements and to carry out site surveys.

The new ‘Micro-mix’ vessels are part of Suncombe extensive range of Tanks, Vessels, Hygienic Processing Systems and Cleaning In Place Systems.

For further information please contact:
Steve Overton – Operations Director
Suncombe Ltd
Jade House
Lockfield Avenue
Brimsdown
Enfield
Middlesex
EN3 7JY,
United Kingdom
Tel: +44 (0) 20-443-3454
Fax: +44 (0)20-443-3969
Web: www.suncombe.com

###

Press Contact: Steve Overton
Company Name: SUNCOMBE LTD
Email: email protected from spam bots
Phone: 44-0208-443-3454
Website: www.suncombe.com

¶ 11:34 PM 0 comments

Online Marketing Group [OMG] Inks Consulting Agreement With Seasilver USA, Inc.

Online Marketing Group [OMG], a Web development and direct response marketing consulting firm located in Hawaii announced today that it has signed an agreement with Seasilver USA, Inc., located in Carslbad, California, to provide marketing consulting services to Seasilver USA, Inc.

Naalehu, HI, - April 21, 2006 -- Online Marketing Group [OMG, a Web development and direct response marketing consulting firm, located in Hawaii, announced today that it has signed an agreement with Seasilver USA, Inc, located in Carslbad, California, to provide marketing consulting services to Seasilver USA, Inc.

Seasilver USA, Inc. is a thirteen year old manufacturer of a whole-food liquid dietary supplement called Seasilver(R), which provides a naturally balanced source of vitamins, minerals, enzymes, and amino acids. The proprietary formula of Seasilver(R) contains Matrix Aloe Vera(tm), Sealogica(R)-a blend of 7 sea vegetables, Pau D'Arco Extract, and four concentrated fruit juices. There are no synthetic man-made nutrients in Seasilver(R).

Seasilver USA, Inc. pioneered the formulation of advanced liquid nutritional supplements and the Seasilver(R) product has wide consumer acceptance because of its convenience-of-use. Liquid supplements appeal to consumers who have difficulty taking pills-such as some seniors and small children, and those living a busy and active lifestyle.

Seasilver is marketed in the United States through a direct selling organization of independent distributors.

Online Marketing Group [OMG will consult with Seasilver USA, Inc. in the areas of Online Marketing Strategies, Search Engine Optimization, Online Advertising, Publicity, Sales Lead Generation, Online Branding, and a comprehensive Article Marketing Program.

The goal of the agreement is to advance the competitive position of Seasilver USA, Inc. and to provide new levels of service, and streamlined online marketing tools, to the distributor network.

More information about Online Marketing Group [OMG is available at the Online Marketing Resource Center(tm) at: http://www.E-ComProfits.com , 808-929-7377.

Additional information regarding Seasilver USA, Inc. is available through their corporate website at: http://www.Seasilver.com.

Details of the Seasilver(R) product, and the home-based business opportunity, is also available at: http://www.SeasilverWellness.com

Press Contact: Thom Reece
Company Name: ONLINE MARKETING GROUP
Phone: 808-929-7377
Website: http://www.e-comprofits.com

¶ 10:31 AM 0 comments

Defective Heart Valves, Pacemakers, and Defibrillators Propose New Risks to Weak Heart Patients

Millions of men and women have heart devices implanted to save them from heart attack not increase their risks of heart attack

New York City, New York (PRWEB) April 20, 2006 -- In the last few years, the technology of heart devices has advanced but many recalled devices are being surgically removed after the discovery of fatal defects.

Patients with heart defects or disorders of the aortic or mitral valve may need a mechanical heart valve. Mechanical heart valves simulate real heart valves to maintain the proper flow of blood into and out of the heart. These patients must take anticoagulation medicine, like Warfarin (coumadin) to prevent deadly blood clots.

Years after their removal from the market, St. Jude’s Silzone and Bjork Shiley’s Convexo-Concave heart valves are still causing serious problems in patients. To support patients with St. Jude or Bjork Shiley heart valves or other recalled heart devices, LawyersandSettlements.com accepts consumer complaints at: Bjork Shiley Heart Valves
Or
Silzone Mechanical Heart Valves

The St. Jude Silzone Heart Valve was implanted into patients from 1997 to 2000 and was recalled due to leaking and device failure linked to serious fatal risks. One study showed that Silzone heart valves increased a patient’s risk of thrombosis/blood clot, embolism, and stroke.

Bjork Shiley distributed their Convexo-Concave (BSCC) heart valves from 1979 to 1986 but over 86,000 defective valves are still implanted in patients worldwide. These valves have remained in thousands of patients due to fatal risks associated with the surgical removal process. These valves have been linked to hundreds of deaths when the defective valve fractured and weaken the device.

About Online Legal Marketing (OLM) and www,lawyersandsettlements.com
OLM is a privately held Internet marketing company. LawyersandSettlements.com offers up-to-date information on legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can complete free case evaluations and subscribe to free newsletters. Justice for Everyone

Visit us at:
LawyersandSettlements.com

Contact us at:
604-608-3435

Press Contact: Scott Wurtele
Company Name: ONLINE LEGAL MARKETING LTD.
Phone: 604-608-3435
Website:  Lawyersandsettlements.com/case/bjork_shiley_heart_valves

¶ 1:16 PM 0 comments

Cancer Chemotherapy Concession

The April edition of CancerWire focuses on the “Chemotherapy Concession” which allows oncologists to make a profit on the chemotherapy drugs that they prescribe to cancer patients.

(PRWEB) April 19, 2006 -- A recent study published in the journal Health Affairs “Does Reimbursement Influence Chemotherapy Treatment for Cancer Patients” revealed that the so-called “Chemotherapy Concession” is still in effect and that financial reimbursement has a direct effect on which chemotherapy drugs are prescribed to patients.

This study by researchers from the University of Michigan and Harvard University found that oncologists who were more generously reimbursed prescribed more costly chemotherapy regimens to metastatic breast, colorectal, and lung cancer patients. The study demonstrated that the chemotherapy concession (doctors making profits from prescribing chemotherapy) that brought Congressional attention several years ago is still with us and is still controlling prescribing patterns.

The Chemotherapy Concession
Unlike other doctors, medical oncologists (doctors who prescribe chemotherapy) can profit directly from prescribing certain drugs. Oncologists can purchase chemotherapy at lower prices than the amounts that the insurance company pays them and then pocket the difference. This mark-up, which can be as high as 86%, is called the chemotherapy concession. The Health Affairs study revealed that this type of reimbursement prompts some oncologists to use more expensive drugs with better mark-ups for the doctor. For example, the study found that for breast cancer patients, a one-dollar increase in a physician’s reimbursement resulted in the use of chemo drugs that cost $23 more. The authors said, "Although reimbursement seems to have little effect on the primary decision to administer palliative chemotherapy to patients with advanced solid tumors, it appears to affect the choice of drugs used."

Why This Hurts Patients
The Chemotherapy Concession can harm patients in at least three different ways: 1) it creates a potential conflict of interest; 2) it may expose patients to more experimental drugs; 3) it may deplete a patient’s insurance benefits (i.e. drug coverage).

Potential Conflict of Interest - The Chemotherapy Concession gives oncologist other reasons to prescribe chemotherapy and select specific drugs. Patients must now ask why their doctor is prescribing more and different chemo. What is behind the decision? Oncologists insist that money has nothing to do with it. But, a New York Times article about the University of Michigan/Harvard Study (“Study links cancer doctors’ pay and their treatment”) cites Dr. Craig Earle, one of the study's authors and an associate professor of medicine at Harvard and an oncologist at the Dana- Farber Cancer Institute in Boston. According to the Times, Dr. Earle stated that despite their insistence that oncologists’ treatment decisions are based solely on what is best for the patient, these decisions are affected by payment policies and other financial influences, including gifts from drug companies.

Newer Experimental Therapies - Typically more costly chemotherapy drugs with higher reimbursement are those that are newer. Because the newer drugs have less of a track record in terms of safety and efficacy (i.e. less post approval marketing surveillance), there may be less known about their safety and efficacy. Therefore, it is possible that a patient may get a drug that is more dangerous to them or less efficacious because of a monetary incentive.

Patient’s Insurance - Someone is paying to put that extra money in the oncologists’ pockets. Because the costs of premiums are directly related to expenditures, the chemotherapy concession hurts all of us by siphoning money away from patients, employers and payers and into the hands of one class of provider.

What You Can Do
Obviously, a patient wants a clinical decision to be based only on clinical information, not on how much money the doctor gets to keep. If you are a patient, you should know if there are any financial incentives at work in determining what cancer drugs you are being prescribed. Ask your oncologist: Why are you prescribing these drugs? What is their published efficacy and toxicity in other patients with the same cancer? Do you have any research or financial interests in prescribing these drugs? Are these drugs a profit center for you in respect to reimbursement?

Obviously you do not want a confrontational relationship with your doctor. And just because a doctor makes a profit from the drugs they prescribe does not mean that the drugs are inappropriate for you. A trusting partnership between doctor and patient that facilitates informed consent is the goal for many proactive patients. Such a partnership, however, may require an understanding of all the factors that lead to a treatment recommendation.

MORE INFORMATION:

•    To read CancerWire: http://www.cancermonthly.com/cancerwire.asp
•    To subscribe to CancerWire: http://www.cancermonthly.com/newsletter.asp
•    For more information about tests that can help a patient determine which chemotherapy can actually work: http://www.cancermonthly.com/chemotherapy.asp
•    For more information about immune boosting products in cancer: http://www.cancermonthly.com/immune.asp
•    For more information about clinics that treat cancer: http://www.cancermonthly.com/clinics.asp
•    For more information about financial support for cancer patients: http://www.cancermonthly.com/financial.asp
•    For more information about legal options for mesothelioma patients: http://www.cancermonthly.com/legal_services.asp

Of course, none of this information in CancerWire is a substitute for professional medical advice, examination, diagnosis or treatment and you should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. No information contained in Cancer Monthly or CancerWire including the information above, should be used to diagnose, treat cure or prevent any disease without the supervision of a medical doctor.

Press Contact: Michael Horwin
Company Name: CANCER MONTHLY
Phone: 919-570-8595
Website: http://www.cancermonthly.com

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute
or defend your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/ 
 __________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

¶ 10:05 AM 0 comments

Ortho Evra Birth Control Patch Allegedly Linked to Heart Attack and Stroke

With 60% more estrogen than birth control pills, the health risks of Ortho Evra Patch are increased

New York City, New York  - April 17, 2006 -- The popular, widely promoted birth control patch contains more hormones than the traditional birth control pill and these hormones, progestin, estrogen, and norelgestromin, are delivered directly into the blood stream via a transdermal skin patch.

Whether caused by the high levels of hormones or the delivery method, Ortho Evra has been linked to blood clots, heart disease, stroke, and death in young adult women.

With reports of women dying from unexpected heart problems, the FDA recently asked the maker of Ortho Evra to revise the label to warn against the risk of blood clot, stroke, or heart attack. A woman’s risk of these side effects also increases with age, smoking habits, and pre-existing conditions such as diabetes, high blood pressure, or high cholesterol.

A leading law firm, advertising on LawyersandSettlements.com, offers free case evaluations to women who have suffered blood clots, stroke, or other side effects from Ortho Evra; for more information, go to:
www,lawyersandsettlements.com/case/ortho_evra

About Online Legal Marketing (OLM)
OLM is a privately held Internet marketing company. LawyersandSettlements.com offers up-to-date information on legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can complete free case evaluations and subscribe to free newsletters.

Visit us at:
www,lawyersandsettlements.com

Contact us at:
1-604-608-3435

###

Press Contact: Scott Wurtele
Company Name: ONLINE LEGAL MARKETING LTD.
Phone: 604-608-3435 
www,lawyersandsettlements.com/case/ortho_evra

¶ 9:12 AM 0 comments

ONE Magazine Launched New Quarterly: Smart Step in Consumer-Focused Healthcare

A new consumer publication – ONE – has launched this month, instantly becoming one of metro Denver’s largest circulation magazines. The 300,000-circulation quarterly magazine focuses on health and well being and establishes HCA-HealthONE LLC as the leading source of healthcare information for area consumers.

DENVER (PRWEB) April 15, 2006 -- A new consumer publication – ONE – has launched this month, instantly becoming one of metro Denver’s largest circulation magazines. The 300,000-circulation quarterly magazine focuses on health and well being and establishes HCA-HealthONE LLC as the leading source of healthcare information for area consumers.

ONE is the insider’s guide to current health and wellness trends. The first issue contains articles of interest to all ages and genders: from knifeless brain surgery to preventing sports injuries and much more. The next issue, due out in January, will continue to serve as a road map for asking the right questions and finding the right answers about healthcare today.

“Until ONE, people in metro Denver haven’t had a reliable, single source devoted solely to medical information and healthcare news,” says Linda Kanamine, HealthONE Vice President of Public Affairs. “I think they’ll be surprised to read about the amazing array of research, treatments and medical technologies that exist right here in their own backyards.”

HealthONE partnered with Wiesner Publishing LLC to publish the glossy, four-color magazine. As the first publication of its kind in Denver, Publisher Maureen Regan says, “It is so encouraging to be a partner with a company that is breaking ground in their efforts to connect with people in their communities and provide information that will ultimately make us all smarter healthcare consumers.”

The medical industry is constantly changing with new technologies, new treatments and new preventions developing every day. “The need to stay informed and to become better educated has never been greater,” Kanamine adds. “ONE was created to be a support system for Coloradans to navigate the complicated world of staying healthy.”

In addition to copies mailed to homes, the magazine can be obtained at Cherry Creek Shopping Center, the Denver Chamber of Commerce or any HealthONE hospital.

HealthONE is the largest healthcare system in the metro Denver area with 8,700 employees and 3,000 affiliated physicians. Recently named Colorado's "Best Company for Working Families -- large business category," the health system was created in 1995 as a 50/50 joint venture between various affiliates of HCA and HealthONE Alliance, a Colorado nonprofit organization.

HealthONE includes: The Medical Center of Aurora and Centennial Medical Plaza; North Suburban Medical Center; Presbyterian/St. Luke's Medical Center; Rose Medical Center; Sky Ridge Medical Center; Spalding Rehabilitation Hospital; Swedish Medical Center; seven surgical centers; more than 35 occupational medicine/rehabilitation, Broncos Sports Medicine, specialty, and outpatient diagnostic imaging clinics; as well as AIRLIFE, which provides critical care air and ground transportation for the HealthONE system.

# # #

Press Contact: Amy Santisi
Company Name: HealthONE
Email: email protected from spam bots
Phone: 303-584-6038
Website: http://www.onemagazineonline.net

¶ 12:11 PM 0 comments

Filmmaker Delivers One-two Punch to Big Pharma

Filmmaker Kathleen Slattery-Moschkau's film, Side Effects, is causing a stir across the nation for its insider's look at the pharmaceutical industry. For those who missed the storm of buzz during its rolling theatrical release, Side Effects will be released to DVD May 16 and sold in Borders, Best Buy and Circuit City stores across the United States, and online at www.sideeffectsthemovie.com and www.Amazon.com. Side Effects, which has been heralded as a light and entertaining approach to a heavy issue, examines the pill-pushing tactics of big pharma, and stars Katherine Heigl, sexy intern on ABC’s award-winning drama, Grey’s Anatomy.

LOS ANGELES, CA (PRWEB) April 12, 2006 -– Causing a stir across the nation, sold-out audiences have flocked to see the eye-opening indie film that the pharmaceutical industry wishes would go away. For those who missed the storm of buzz during its rolling theatrical release, Side Effects will be released to DVD May 16 and sold in Borders, Best Buy and Circuit City stores across the United States and online at www.sideeffectsthemovie.com and www.Amazon.com.

Side Effects, which has been heralded as a light and entertaining approach to a heavy issue, is an insider’s look at the pharmaceutical industry and stars Katherine Heigl, sexy intern on ABC’s award-winning drama, Grey’s Anatomy.

Since its world premiere a year ago, writer/director Kathleen Slattery-Moschkau continues to be stunned by the level of interest from consumers, physicians and the holistic community. The film is making a tremendous impact because Slattery-Moschkau speaks from experience. Based on her decade working as a drug sales rep, Side Effects examines the pill-pushing tactics of the pharmaceutical industry’s leading companies.

After releasing Side Effects to the public, Slattery-Moschkau went on to make Money Talks: Profits Before Patient Safety, a revealing documentary that examines the ethics of marketing within the drug industry, which will be available May 16, online only.

True to her position since the beginning, Slattery-Mosckau continues to take a reasoned approach to the issues surrounding the industry. “We need to acknowledge that we need prescription medications, but understand that the current system is broken—-these are the first steps toward progress,” says Slattery-Moschkau.

With Michael Moore’s film Sicko due out in fall of 2006, the pharmaceutical industry will have its hands full this year. “For me, this is not a witch hunt,” says Slattery-Moschkau. “It’s about accountability, raising awareness, and leveling the playing field—the beauty of a free market system.”

To arrange an interview with Kathleen Slattery-Moschkau, contact Cari Reisinger of Hummingbird Pictures at (414) 264-1065.

###

Press Contact: Cari Reisinger
Company Name: HUMMINGBIRD PICTURES
Email: email protected from spam bots
Phone: 414-264-1065
Website: www.sideeffectsthemovie.com

__________________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
__________________________________________________________
Merck Vioxx is one of many current hot topics, find information at:
http://www.vioxx-search-engine.com
__________________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
__________________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute  
or defend your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/
__________________________________________________________
http://www.legal-search-engine.com
http://www.drug-store-directory.com
__________________________________________________________

 

 

¶ 9:09 AM 0 comments

Vertrue Announces $10 Million Discount Drug Card Donation

to be administered by local United Way agencies

Norwalk, Conn. (PRWEB) April 12, 2006 -- Vertrue Incorporated (NSDQ: VTRU) today announced the donation of $10 million worth of pharmacy savings cards to uninsured and underinsured families throughout the United States. The Familywize discount prescription drug cards, issued by Vertrue’s Coverdell & Company subsidiary, are valued at $29.99 each and provide point-of-sale discounts on prescription drug purchases at major pharmacies and drugstores nationwide.

Through this partnership with Membership Services Corporation, needy families will receive the Familywize cards through participating United Way agencies. The first $5 million in cards were shipped to United Way agencies this month and the remainder will be distributed throughout 2006.

“Too many American families have insufficient or no prescription drug coverage at all,” said Debbie Flinn, Community Investment Director of the United Way agency of Danville-Pittsylvania County, Virginia. “The Familywize discount prescription drug cards will help families who otherwise could not afford much needed prescription drugs.”

“Vertrue is very excited to partner with United Way agencies and Membership Services Corporation to get the Familywize card into the hands of families who most need the help,” said Gary Johnson, President and Chief Executive Office of Vertrue. “These cards can reduce prescription drug costs by an average of 20 percent.”

“Working with reputable and established charities like local United Way agencies is the best way to reach the people who really need to save money on prescription drugs” said Dan Barnes, President of Membership Services Corporation.

About Vertrue
Headquartered in Norwalk, Conn., Vertrue Incorporated is a leading Internet marketing services company. Vertrue gives consumers access to services that offer substantial discounts and convenience for important decisions in their everyday lives. Vertrue's valued services span healthcare, personal property, security/insurance, discounts and personals and are all offered online through an array of marketing channels. Vertrue is a premier marketing partner to corporate clients, and its services enable partners to enhance market presence, strengthen customer affinity and generate additional value.

About Membership Services Corporation
Membership Services Corporation of Bethlehem, Pennsylvania has specialized for more than 15 years in affinity marketing and strategic sourcing to deliver quality benefits, reliable services and measurable savings.

###

Press Contact: Sandy
Company Name: Vertrue
Email: email protected from spam bots
Phone: 202-486-7575
Website: www.familywize.com

¶ 7:45 AM 0 comments

UAMS Myeloma Researchers on Team Analyzing Disease's Genetic Fingerprints -- Cancer Cell Publishes Work That Could Lead to New Treatments

Researchers at the University of Arkansas for Medical Sciences (UAMS) are part of a team that has identified that multiple myeloma, a cancer of the blood, could actually be several different diseases at the cellular level with a potential for genetically targeted treatments that could extend to other forms of cancer. The research is published in the April 2006 issue of journal Cancer Cell.

Little Rock, AR (PRWEB) April 11, 2006 -- Researchers at the University of Arkansas for Medical Sciences (UAMS -- http://www.uams.edu) are part of a team that has identified that multiple myeloma (http://myeloma.uams.edu), a cancer of the blood, could actually be several different diseases at the cellular level with a potential for genetically targeted treatments that could extend to other forms of cancer.

The research is published in the April 2006 issue of journal Cancer Cell. The article, "Tracking genome changes during cancer initiation, progression and treatment sheds light on multiple myeloma," is now available online at http://www.cancercell.org/.

UAMS myeloma researcher John D. Shaughnessy Jr., Ph.D., was one of three lead authors of the study, along with Ron A. DePinho, M.D., of the Dana-Farber Cancer Institute/Harvard Medical School, and Cameron Brennan, M.D., of Memorial Sloane-Kettering Cancer Center. Shaughnessy is director of the Lambert Laboratory of Myeloma Genetics in the Myeloma Institute for Research and Therapy (http://myeloma.uams.edu), which is part of the Arkansas Cancer Research Center at UAMS (http://www.acrc.uams.edu), and an associate professor in the UAMS College of Medicine (http://www.uams.edu/com).

"The new research, based on analysis of myeloma cells, is a significant step in understanding the genetic basis of myeloma development and progression," Shaughnessy said. "The study suggests that myeloma consists of at least seven different genetic subtypes of disease," he said.

"This represents a watershed in myeloma research since multiple myeloma's genetic complexity had previously kept us from determining if it was actually more than one disease," Shaughnessy said. "Now we can begin to better separate patients by the effect myeloma is having on them at the genetic level and develop targeted treatments based on that knowledge.

"Development of so-called targeted therapies, aimed at specific genetic mutations and biochemical pathways affected within cancer cells is being utilized now in some cancers like chronic myelogenous leukemia and is a hope for all cancers."

Several of the genes identified in the study also are associated with unrelated cancers, including pancreatic, lung, breast and ovarian cancer.

About the Myeloma Institute for Research and Therapy:

The MIRT (http://myeloma.uams.edu) continues to be at the forefront of myeloma research with this latest publication. Studies of myeloma treatment methods, led by Bart Barlogie, M.D., Ph.D., director of the MIRT, were published in the April issue of Blood, the journal of the American Society of Hematology as well as the March 9 issue of the New England Journal of Medicine.

Barlogie's work was recognized in March when the organization responsible for publishing the annual America's Top Doctors named him a national physician of the year. The selection was based on nominations submitted by physicians profiled in America's Top Doctors.

Multiple myeloma (http://myeloma.uams.edu) is a type of cancer that involves plasma cells -- white blood cells that produce antibodies. It is the second most common cancer of the blood.

When plasma cells become cancerous, they reproduce uncontrollably and crowd out healthy red and white blood cells, preventing them from fighting infection and carrying oxygen throughout the body. Bone destruction is a common manifestation of myeloma. The malignant cells also produce a type of protein that can cause kidney failure.

Research at the MIRT has more than doubled the annual survival rate of a myeloma patient upon diagnosis from three years to seven years and beyond.

About the University of Arkansas for Medical Sciences (UAMS):

UAMS is the state's only comprehensive academic health center, with five colleges, a graduate school, a medical center, five centers of excellence and a statewide network of regional centers. UAMS has about 2,320 students and 690 medical residents. It is one of the state's largest public employers with almost 9,000 employees, including nearly 1,000 physicians who provide medical care to patients at UAMS, Arkansas Children's Hospital and the VA Medical Center. UAMS and its affiliates have an economic impact in Arkansas of $4.3 billion a year.

Contact:
Andrea Peel, 501-686-8996
Wireless Phone, 501-351-7903
http://www.uams.edu | http://myeloma.uams.edu

###

Press Contact: Shane Tripcony
Company Name: UAMS
Email: email protected from spam bots
Phone: 501-686-8996
Website: http://myeloma.uams.edu

¶ 7:07 PM 0 comments

New Smoking Cessation Program Resolves the Real Reason that People Smoke

New discovery addresses the real reason why 84% of smokers fail when they try to quit. According to EFT, the driver behind most addictions is the need to tranquilize or medicate emotions. EFT is an easy to learn acupressure technique that successfully addresses the emotional drivers that fuel the ongoing addiction.

San Francisco, CA (PRWEB) April 11, 2006 -- Smokers typically use nicotine replacement or they “go cold turkey” to quit smoking. They also typically fail. In fact the US FDA reports that 70% of smokers want to quit, but more than 84% of them are unsuccessful in their attempts. Gary Craig, Stanford trained scientist and founder of Emotional Freedom Techniques (EFT) explains that, “conventional smoking cessation systems don’t work because they do not address the real reason that people smoke which is to tranquilize emotional issues like anxiety or low self esteem.”

Craig initially developed Emotional Freedom Techniques (EFT) as a self-help tool for people with emotional difficulties but soon received reports from smokers who said that their craving for cigarettes subsided or disappeared while performing EFT for their emotional issues. These results didn’t surprise Craig who maintains that, “smokers are tranquilizing their emotions with tobacco and will find quitting enormously difficult until those emotional issues are resolved.

The National Institute on Drug Abuse (NIDA) reports that people suffering from nicotine withdrawal have increased aggression, anxiety, hostility, and anger. However, Craig doesn’t attribute these emotional responses to nicotine withdrawal. He says, “smokers become anxious and irritable when they try to quit smoking because the unresolved emotions they had been trying to suppress with cigarettes come bubbling to the surface as nicotine exits their system.”

Craig maintains that using EFT to resolve these emotions will help smokers to conquer this life threatening addiction permanently. “If emotional issues aren’t properly resolved, the smoker feels overwhelmed and eventually turns back to cigarettes to pacify the emotional pain.”

EFT is a simple technique that combines focused thought with gentle fingertip tapping on key acupressure points. Craig says, “The main cause of all negative emotions is not where psychologists have been looking. Instead, it involves the disruption of the energy pathways in the body. Once these pathways are balanced, the emotional drivers behind smoking and other addictions start to fade.”

Dr. Carol Look is a Clinical Hypnotherapist and EFT Practitioner who has helped many clients quit smoking. Dr. Look reports, “While I used hypnosis successfully for many smokers, I found that treatment using EFT gave the client more control, empowerment, and an active tool they could pull out and use whenever they wanted.”

Pat Farrell is another Clinical Hypnotherapist who prefers to use EFT for smoking cessation. One woman came to Farrell because she had quit smoking many times but had recently resumed smoking around the occasion of her wedding anniversary; a painful time since her husband had left her three years previously for a younger woman.

With EFT, Farrell helped her client collapse feelings of overwhelming sadness and betrayal as well as her immediate physical cravings for cigarettes. Farrell also addressed the woman’s habitual craving for cigarettes with her morning coffee. They worked together for about an hour and only spent three minutes on the actual cigarette craving. The rest of the time they addressed the emotional drivers fueling the woman’s need for cigarettes.

Two weeks after treatment, Farrell’s client still had no desire for a cigarette. She accomplished this without psychotherapy or nicotine replacement.

Anybody can learn to use EFT to eliminate cigarette cravings and even to quit smoking entirely. Gary Craig explains, “smokers generally expect to fail when they set out to quit. But when they use EFT, most experience an instant reduction in their cigarette craving. Their level of hope increases as their cravings decrease. If they persistently use EFT to address the emotional component of their addiction, they are likely to have a high success rate.”

If smoking cessation programs incorporated the proper use of EFT, Craig predicts that their success rate would be about between 50 and 80 percent - instead of the current 84% failure rate.

More than 225,000 people have downloaded Craig’s free training manual and another 5,000 to 10,000 download it each month. Known as The EFT Manual, it has been translated by volunteer practitioners into nine languages. The EFT website is the sixth most actively visited natural health site in the world.

The EFT Manual gives anyone all the basics so they can apply it right away. It can be freely downloaded at…

http://www.emofree.com/downloadeftmanual.asp?ref=prw-smoking

For further information contact Gary Craig at 707-785 2848

###

Press Contact: Gary Craig
Company Name: EFT
Email: email protected from spam bots
Phone: 707-785 2848
Website: http://www.emofree.com?ref=prweb-smoking  

 

¶ 9:00 AM 0 comments

New PQ Media Research: Blog, Podcast, RSS Advertising Grow Fastest Among Alternative Media, Surging 198% in 2005, and Forecast to Grow 145% in 2006 Study Finds Podcast Advertising Will Be Larger Than Blog Market by 2010

Combined U.S. spending on blog, podcast and RSS advertising bolted 198.4% to $20.4 million in 2005, and is expected to grow another 144.9% to $49.8 million in 2006, according to exclusive research released today by PQ Media, a custom media research firm.

Stamford, Conn., April 11, 2006 – Combined spending on blog, podcast and RSS advertising bolted 198.4% to $20.4 million in 2005, and is expected to grow another 144.9% to $49.8 million in 2006, according to exclusive research released today by PQ Media, a custom media research firm. But podcast advertising, nonexistent until 2004, is expected to be a larger market than blog advertising by 2010, according to Blog, Podcast and RSS Advertising Outlook, the first of five installments in PQ Media’s Alternative Media Research series. This groundbreaking series, the culmination of more than six months of primary research, is the first source to define, size and structure the burgeoning alternative media sector.

Blog advertising accounted for 81.4%, or $16.6 million, of total 2005 spending on blog, podcast and RSS advertising, collectively known as user-generated online media. But the blog segment will comprise only 39.7%, or $300.4 million, of overall expenditures in 2010. Podcast advertising, meanwhile, reached $3.1 million in 2005, and is projected to grow at a compound annual rate of 154.4% to $327.0 million in 2010, when it will be a larger market than blog advertising. RSS advertising, non-existent until mid-2005, generated $650,000 in 2005.

“Blog, podcast and RSS advertising are being driven by some of the same factors boosting the growth of the overall alternative media sector: continued audience fragmentation, the perceived ineffectiveness of traditional advertising, and the elusive but coveted 18-to-34-year-old demographic,” said Patrick Quinn, president of PQ Media. “Blog, podcast and RSS advertising have demonstrated an ability to reach younger demographics as well as influentials, and the media tend to be highly engaging. These are attractive trends to brand marketers that are focused on return on investment.”

The relatively small size of these markets is an indication of the newness of the media, the lack of standard metrics and various technology issues, Quinn added. “As advertising networks become more effective, user engagement escalates, and the industry works through its technology and measurement challenges, we expect user-generated media to grow at triple-digit rates over the next five years,” said Quinn.

Technology, auto and media brands are the most active in user-generated media advertising, accounting for more than half of total advertising spending in 2005, with the food & beverage and apparel categories rounding out the top five. The technology, auto and media categories will continue to generate more than half of all advertising in 2010.

Total spending on user-generated online media is forecast to grow at a compound annual rate of 106.1% from 2005 to 2010, reaching $757.0 million in 2010, according to Blog, Podcast and RSS Advertising Outlook. By comparison, the overall alternative media industry including, among others, markets such as branded entertainment, digital out-of-home advertising, mobile marketing and video-on-demand marketing, is projected to grow at a compound annual rate of 14.8% in the five-year period to $253.7 billion in 2010.

PQ Media’s Alternative Media Research Series will also include reports covering the overall alternative advertising and marketing industry, including all 22 alternative media segments, and the first report to size and forecast the global market for branded entertainment, among others. These publications are available solely through PQ Media’s website at www.pqmedia.com. An executive summary of Blog, Podcast and RSS Advertising Outlook is available online at http://www.pqmedia.com/blog-podcast-rss-advertising.html.

PQ Media is the world’s leading provider of alternative advertising and marketing research. The firm also delivers exclusive data and information on traditional media, including advertising, marketing services, consumer and business media, and media usage. Founded in 2002, PQ Media has two major practice areas through which we provide custom and syndicated research to brand marketers, media buyers, media companies and financial institutions. PQ Media is located at Two Stamford Landing, Suite 100, Stamford, CT 06902. Phone is 203-921-0368; Fax, 203- 921-0367; E-mail, email protected from spam bots.

Contact: Wendy Marx
Company Name: Marx Communications
Phone: 203-445-2850
Website: www.pqmedia.com  
 ______________________________________________
FREE 1 Year Tech and Business Magazine Subscriptions!
http://consultant-directory.tradepub.com/
______________________________________________
Free lists of over   9 million expired domain names
http://www.bizprolink-internet.com
____________________________________________
Promote your consulting business with a free listing
in our http://www.Consultant-Directory.com
______________________________________________
Professional SEO firm submits to over 180 systems
by hand and shares the list so you can do it yourself!
http://www.Best-Free-Search-Engine-List.com
____________________________________________
Search Engine Industry Professional Organization
http://www.seoby.org
____________________________________________

¶ 8:49 AM 0 comments

Transparency and Investigations and Lawsuits Driving the Growth of Small Pharmacy Benefit Managers, According to a new Knowledge Source Market Overview

Knowledge Source’s Pharmacy Benefit Management Market Overview reveals that two recent developments -- transparency, and the increased pressure and awareness resulting from investigations and lawsuits -- will drive the growth of small pharmacy benefit managers. This report, and company-specific BusIntell Reports, is now available online at www.knowsource.com.

Trumbull, CT (PRWEB) April 7, 2006 –- Knowledge Source, Inc. announced today that it has published a Market Overview on Pharmacy Benefit Managers that is available on their web site or by calling 203-377-0460.

Knowledge Source's Pharmacy Benefit Management Market Overview, 270 pages in length, includes the Market's Overview and Trends, as well as profiles of more than fifty of the leading industry participants which include (when available): company background, company strategy, financial and statistical information, product overview, and recent activities.

The company also announced that company-specific BusIntell Reports on the organizations profiled in the new report are also available online. BusIntell Reports provide a comprehensive strategic analysis of the leading Pharmacy Benefit Managers.

For additional information on the Pharmacy Benefit Management Market Overview or other research reports published by Knowledge Source, please contact John Santilli at 203-377-0460 or visit the company's web site. This Market Overview report is 270 pages in length and purchasable for $345 with immediate online delivery.

About Knowledge Source

Knowledge Source (www.knowsource.com), a national business intelligence and market research firm, has delivered healthcare business information and analyses services to executives who seek a competitive edge since 1989.

Knowledge Source provides healthcare information, syntheses, analysis and presentation services to busy managers who seek actionable market knowledge about clients, competitors, industries or markets in a world with an over-abundance of data.

Contact:

John Santilli
Knowledge Source
203-377-0460
http://www.knowsource.com.

###

Press Contact: Bill Balderaz
Company Name: ECNext
Email: email protected from spam bots
Phone: 614-682-5124
Website: http://www.knowsource.com

¶ 12:08 PM 0 comments

A Lifetime Without Cold Sores With interceptCS

The Gibson Group launches interceptCS, the first product clinically proven and approved for the prevention of Cold Sores (Herpes Simplex -1).

Markham, Ontario, Canada (PRWEB) April 6, 2006 -- The Gibson Group is pleased to announce the launch of interceptCS, an innovative device that completely revolutionizes the management of cold sores (herpes simplex -1). In contrast to other available therapies such as topical or oral antiviral medications, interceptCS doesn’t ‘treat’ cold sores – it prevents them before they start.

Grant Gibson, President of the Gibson Group states, “in all our years in healthcare marketing we have rarely seen a product that has an “approved” prevention claim. interceptCS will revolutionize this category. This will be a significant breakthrough for the 5 to 10 million Canadians who suffer from recurrent cold sore outbreaks. Now, many of these patients can look forward to a lifetime without cold sores.”
       
interceptCS is a unique personal medical device that utilizes precisely targeted Thermal Defence Technology to stimulate the body’s cellular immune response. Patients use the interceptCS Cold Sore Prevention System as soon as they feel the characteristic tingling sensation that indicates a cold sore is about to emerge. interceptCS is quick, painless and convenient to use – just three 30-second treatments safely and effectively prevents the cold sore from developing.

The launch of interceptCS will consist of a national radio campaign, web advertising, and a Pharmacist education program.

The interceptCS Cold Sore Prevention system is available exclusively through Shoppers Drug Mart/Pharmaprix.

With interceptCS, Feel the tingle. Stop your cold sore.™ For further information on interceptCS, call Allison Boyd of The Gibson Group at 905-475-0371 or visit: www.interceptCS.com.

For further information on The Gibson Group please visit our web site at www.thegibsongroup.ca or call Allison Boyd at 905-475-0371

###

Press Contact: Allison Boyd
Company Name: THE GIBSON GROUP
Email: email protected from spam bots
Phone: 905-475-0371
Website: www.thegibsongroup.ca

¶ 9:50 AM 0 comments

Mettler Toledo Announces Tailored Weighing Solutions for the Pharmacy

Mettler Toledo is pleased to introduce a new line of balances: The Mettler Toledo Pharmacy Line. Tailored to the needs of pharmacies worldwide, it offers dedicated software solutions and the most reliable weighing technology for trouble-free operation day-in and day-out.

(PRWEB) April 6, 2006 -- Mettler Toledo is pleased to introduce a new line of balances: The Mettler Toledo Pharmacy Line. Tailored to the needs of pharmacies worldwide, it offers dedicated software solutions and the most reliable weighing technology for trouble-free operation day-in and day-out.

Dedicated Software
Mettler Toledo has researched the needs of pharmacies and includes a dedicated software solution in the balances:
• Mixing formulations and medications with the function “Formula” - with the touch of one button.
• Counting pills or tablets is easy using the counting application.
• Assuring accurate results in unstable environments with the vibration adapter.

Designed for Pharmacies
All balances in the Pharmacy Line have a customized design: The Aesculap symbol is internationally understood and points out that this balance is made for pharmacies. All 1mg and 0.1mg balances are equipped with a draft shield , which can be easily cleaned.

Accurate and Reliable
Temperature changes can influence the accuracy of the weighing results. Thanks to the Fully Automatic Calibration Technology (FACT), the balance eliminates these effects -for accurate results under all conditions. Pharmacy balances also come standard with a rugged metal housing and Monobloc™ load cell “Which gives users the accuracy and security users need when analyzing results,” States Weighing Specialist, Craig Rowles. “Mettler Toledo has been able to put its years of expertise and application knowledge into an industry-specific product which is almost unheard of in the weighing industry.”

Complete Product Range
The Pharmacy Line comprises a broad portfolio of balances for use in pharmacies. From a 0.01g precision balance up to a 0.1mg analytical balance - users will find the perfect balance for their pharmacy.

Mettler Toledo is a leading global supplier of precision instruments and is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. Mettler Toledo provides weighing solutions that help customers by automating processes, increasing yields, controlling product quality and complying with industry standards and regulations. Additional information about Mettler Toledo can be found on the website www.mt.com/pharmacy.

# # #

Press Contact: Chellsea Mastroine
Company Name: METTLER TOLEDO
Email: email protected from spam bots
Phone: 614-438-4936
Website: www.mt.com

¶ 9:21 AM 0 comments

MedMeme, LLC Announces Launch of ProfileMeme(tm) - A New Database that Identifies Medical Opinion Leaders Worldwide

MedMeme, LLC announces the launch of ProfileMemeTM, a new comprehensive database of the top physicians and scientists working in health care worldwide. MedMeme, with its unique process to identify, profile, and rank established and emerging medical opinion leaders, promises to save clients time and money in their global opinion leader identification efforts.

New York, NY (PRWEB) April 5, 2006 -- MedMeme, LLC announces the launch of ProfileMemeTM, a new comprehensive database of the top physicians and scientists working in health care worldwide. MedMeme, with its unique process to identify, profile, and rank established and emerging medical opinion leaders, promises to save clients time and money in their global opinion leader identification efforts.

Company CEO, Mahesh Naithani, says “using MedMeme’s collective resources and scientific methodology gives ProfileMeme™ an objective and comprehensive advantage that pharmaceutical manufacturers, and others, can depend on as an innovative alternative to the costly, time-consuming and subjective methods currently used to identify Medical Opinion Leaders (MOLs). It is the best, quantifiable, objective method to identify and select the right MOL.”

ProfileMeme’s™ database instantly identifies MOLs using selection criteria such as: disease, indication, treatment interest, and geography, for example. ProfileMeme™ includes more than 200,000 physicians and scientists worldwide, ensuring clients can select exactly the thought leaders most relevant to their needs.

A recent study revealed that in the last seven years, the pharmaceutical industry has seen a 300% increase in physician-led promotional events versus sales rep-led events. As pharmaceutical marketers begin to move away from a strategy of escalating volumes of reps and promotion, companies are exceedingly interested in MedMeme’s more efficient and less subjective methods to identify these all-important physicians.

About MedMeme, LLC

Using independent, authoritative, forward-looking insights into the competitive marketplace, MedMeme™, LLC specializes in collection and analysis of clinical and medical marketing intelligence, an invaluable service for pharmaceutical and medical products companies, physicians, and medical societies. While it uses a broad base of data resources, it focuses on medical conferences because they have rapidly become the important place where professionals and the healthcare industry effectively meet to interact and exchange information, a trend driven by increasing cost and decreasing effectiveness in traditional forms of communication with physicians.

For further information about the Profilememe™ MOL database, please contact Ron Nick at (312) 972-0611 or e-mail at ronaldmnick -at- medmeme.com.

Media contact:
Yan Barshay
Phone: (212) 725-5992
email: yan -at- medmeme.com

# # #

Press Contact: Yan Barshay
Company Name: MEDMEME, LLC
Email: email protected from spam bots
Phone: 212-725-5992
Website: www.medmeme.com

¶ 9:56 AM 0 comments

Fibromyalgia Symptoms Relieved with Natural Ingredients

Fibromyalgia sufferers can now find fibromyalgia symptom relief with Fibro-Balance, a natural fibromyalgia nutritional supplement that uses organic and natural ingredients to help the body relieve the painful symptoms of fibromyalgia. Fibro-Balance is provided by Fibromyalgia-Support.org, a premier natural medicine and fibromyalgia support website and company.

(PRWEB) April 5, 2006 -- Fibromyalgia sufferers can now find fibromyalgia symptom relief with Fibro-Balance, a natural supplement that uses organic ingredients to help the body balance the nutrition required for healing.

Fibro-Balance is a unique formula designed by Dr. Edward F. Group III, Chief Executive Officer of The Global Healing Center, to provide natural help for fibromyalgia symptoms. Fibro-Balance contains proven ingredients such as organically-certified herbs, oxygen-enhancing ingredients, glyconutrients, and more. The product was designed with pure organically-certified and natural ingredients to ensure maximum efficacy.

"We thought it was important that people could find answers to the dreaded diagnosis and get relief from the fibromyalgia symptoms using a researched natural health supplement that is organically-based and premium quality," said Dr. Group. "Fibro-Balance has been carefully researched to provide optimum results for relieving pain and suffering the natural way."

Fibro-Balance has several benefits for fibromyalgia sufferers, such as relieving pain and stiffness, depression symptoms, inflammation of sore muscles, and afternoon fatigue. It attacks fungus and hidden viruses and helps regulate the immune system. Fibro-Balance also promotes restful sleep.

In addition to the Fibro-Balance, www.fibromyalgia-support.org website is a source for in-depth information on fibromyalgia and how to treat it. The website has information on symptoms and diagnosis of fibromyalgia, as well as treatment suggestions and information on joining a fibromyalgia support group.

Visit www.fibromyalgia-support.org to:
* Get Fibro-Balance for help with fibromyalgia symptoms
* Read extensive information on fibromyalgia
* Join the online community
* Sign up for a free newsletter and e-course
* Fibromyalgia Secrets Revealed E-Book

###

Press Contact: Dr. Edward F Group III
Company Name: Fibromyalgia-Support.org
Email: email protected from spam bots
Phone: 713-476-0016
Website: http://www.fibromyalgia-support.org

¶ 9:53 AM 0 comments

Sutter Health Selects EnovateIT to Assist with Ergonomic Support of Patient Safety Technology

Sutter Health, one of the nation’s leading not-for-profit health care systems, has selected EnovateIT, the leading integrator of wireless mobile point-of care workstations to assist with purchasing of point-of-care carts and wall mounts. These workstations will help advance electronic health record (EHR)and patient safety initiatives within the Sutter system.

Troy, MI (PRWEB) April 4, 2006 – Sutter Health, one of the nation’s leading not-for-profit health care systems, has selected EnovateIT, the leading integrator of wireless mobile point-of care workstations to assist with purchasing of point-of-care carts and wall mounts.

Sutter Health is in the process of deploying network wide a powerful electronic health record (EHR) system that will electronically connect more than 5,000 physicians, 25 hospitals and millions of patients across its not-for-profit Northern California network. It will give physicians and other approved health care professionals immediate access to secure online medical and patient data, including recent radiology, lab and pharmacy results. Not only will this powerful tool help ensure better, safer and more efficient health care, it also will enable patients to view their own health histories and test results securely online.

“We expect our EHR to set a new standard for patient safety and satisfaction by creating more efficient and accurate systems for caregivers and patients alike,” said Julie Cooper, Sutter Health senior technical project manager. "EnovateIT’s expert guidance will help us in selecting the best mobile carts and wall mounted solutions for this important system."

EnovateIT provided assistance to Cooper, who oversees the selection of a variety of computer carts and wall mounts that will make Sutter’s EHR system from Epic available to clinicians in medical groups and hospitals throughout the Sutter Health network. When the project is complete, Sutter will have successfully deployed 4,000 mobile and wall mounted computer workstations for data capture and the bedside, within support departments such as radiology and admitting, and within physician exam rooms.

The mobile device selection process began in 2005 with over 200 employees providing feedback during the evaluation. They represented a wide range of functional areas, including patient care, clinical informatics, information systems and technology, occupational health, biomedical engineering and infection control. As part of the selection process, EnovateIT listened very closely to Sutter’s IT and clinical staff needs to determine what products would create the best solution for their facilities. The resulting solutions were proven products from multiple manufacturers that improved patient care and enhanced staff efficiency.

“EnovateIT’s knowledge of point-of-care wall-mount and mobile cart solutions and excellent on-site service will permit our IT staff to focus on the software implementation and end-user training,” said Cooper.

Sutter Health had previously partnered with EnovateIT in 2003 to select mobile carts for its barcode technology that helps ensure safe administration of medications at the bedside. As an expert in point-of-care carts, EnovateIT supported Sutter in the roll-out of 1,000 mobile workstations across its 26 hospitals over a two-year period.

"We are pleased that EnovateIT will be an integral part of this multi-faceted EHR initiative at Sutter Health. The solid foundation laid with them during the barcode project will be further built upon as we work with Sutter to provide optimal point-of-care workstation solutions that meet their specific clinical needs," said Dave Sanders, Western Regional Sales Manager, EnovateIT.

About Sutter Health
Sutter Health is a family of not-for-profit hospitals and physician organizations that share resources and expertise to advance health care quality. Providing personalized care in more than 100 communities throughout Northern California, the Sutter Health network is a regional leader in cardiac care, cancer treatment, orthopedics, obstetrics, and newborn intensive care, and is a pioneer in advanced patient safety technology. For more information, visit www.sutterhealth.org.

About EnovateIT, LLC
EnovateIT is a leading provider of mobile wireless solutions and a premier global systems integrator for healthcare headquartered in Troy, Michigan. With more than 30,000 devices installed in over 500 healthcare facilities, EnovateIT provides secure, cost-effective mobile solutions for medication delivery systems, computerized physician order entry, clinical documentation, and electronic medical records systems. EnovateIT not only offers the products to facilitate wireless point-of-care information solutions, but also the services and support to make it a reality. For more information visit EnovateIT at www.enovateit.com or call 248.655.0548.

# # #

Press Contact: Lynn Spieker
Company Name: EnovateIT
Email: email protected from spam bots
Phone: 248-655-0548
Website: www.enovateit.com

¶ 1:23 PM 0 comments

Licensing Opportunity Available to Pharmaceutical Companies

Med Services Europe reports progress in partnering prescription pharmaceuticals registered for Hormone Replacement Therapy.

Zurich, Switzerland (PRWEB) April 4, 2006 -- Med Services Europe GmbH, a “Virtual European Headquarters” announced progress out-licensing a portfolio of prescription pharmaceutical products registered in several European markets for Hormone Replacement Therapy. (http://www.MedServicesEurope.com).

“Distributors have now been signed for several markets,” explained Dr Emmer. “However, rights are still available for other world-wide markets including several in Eastern and Western Europe and the Mid-East”.

Dr. Emmer explained further about the opportunity that this portfolio presents to pharmaceutical companies “The distributors that we have signed understand that the market for HRT products is very large and growing and is hungry for new launches. They agree that this portfolio offers many interesting advantages for the market”.

Dr Emmer encourages pharmaceutical companies to learn more about the opportunity to in-license this portfolio of products. “This is a unique opportunity to obtain marketing rights to an exciting portfolio of products, which are currently registered in several European markets”
Pharmaceutical companies interested in obtaining more information are encouraged to contact Dr Emmer at Med Services Europe in Switzerland.

About Med Services Europe:
Med Services Europe GmbH is located in Zurich, Switzerland and specializes in Sales, Marketing and Business Development for Pharmaceutical and Medical manufacturers. Med Services acts as a virtual European Headquarters by developing and managing distribution networks for its clients. For more information: http://www.MedServicesEurope.com or +41764249963

###

Press Contact: Dr. Gene Emmer
Company Name: MED SERVICES EUROPE GMBH
Email: email protected from spam bots
Phone: +41764249963
Website: http://www.medserviceseurope.com

¶ 9:40 AM 0 comments

Free Prescription Drugs Available to Households with Incomes as High as $80,000

Drug companies routinely give away free prescription drugs. Free or reduced outpatient prescription drugs for Medicare beneficiaries who have not yet enrolled in Part D. But trying to access the programs can be complicated and time consuming. The Free Medicine Foundation shows consumers how to cut through the drug companies' red tape.

Doniphan, MO (PRWEB) April 4, 2006 -- For individuals needing assistance in affording prescription medication, help may only be a few minutes away.

The Johnson’s have no insurance, and can’t afford the 5 prescriptions they must take daily. However, they get all of them free-of-charge, thanks to the efforts of Free Medicine Foundation and drug-makers.

Three of the Nation’s largest drug makers send the Johnson’s their cholesterol, thyroid, heart, pain and blood pressure medication FREE because they participate in these little-known patient assistance programs that are offered by pharmaceutical companies.

The Johnson’s who found a Free Medicine Foundation brochure application in their doctor’s office said, “It’s the best-kept secret in town, we couldn’t take our medications without them…we wouldn’t be able to afford it.” they said.

Although free medicine assistance has been around for over 50 years, most people have never heard about and do not know how to apply for free medicine. The "Free Medicine Foundation" mission is to inform the media and the public of assistance that may be available to thousands of Americans who don't even realize they qualify for such help. Free Medicine Foundation works tirelessly to match patients with hundreds of free or low-cost available programs by scouring available medicine plans to find plans that match applicant needs.

Cindy Randolph, spokesman for the Free Medicine Foundation organization, said that our efforts have proven successful and have helped hundreds of thousands of Americans. Free prescription drugs are available to individuals who are uninsured or underinsured – with no outpatient prescription coverage for some or all prescription drugs you need, (have maxed their insurance out and/or reached the “gap” or “donut hole”), and who meet certain established income criteria for each medication.

"This is an effort to help people who qualify and don't even know it," said Randolph. This includes Medicare beneficiaries who elect not to enroll in a Medicare drug plan. The Office of Inspector General (“OIG”) notes that “manufacturer-sponsored Patient Assistance Programs (PAPs) need not remove all Medicare beneficiaries from their existing programs to be compliant with federal fraud and abuse laws. Because enrollment in Part D is voluntary, existing PAPs may continue to provide free or reduced outpatient prescription drugs to Medicare beneficiaries who have NOT yet enrolled in Part D.” In addition, individuals who do not meet criteria for income for prescription drug coverage –including Medicare beneficiaries who enroll in the Medicare drug plan – May still qualify for free or low-cost prescription drugs.

Drug sponsors recognize that sometimes exceptions need to be made based on a patient’s individual circumstances. Individuals who do not meet these criteria may still qualify if both they and their physician attest that the patient has special circumstances of financial and medical hardship, and their income is below an established limit. It’s not just poor people who qualify. With each medication the income criteria varies from below the poverty level up to $39,200 for individuals, $52,800 for couples, and as high as $80,000 for a family of four.

Since 1993, Free Medicine Foundation, which is a national program to help patients across the country, access prescription medicines by helping to enroll them in patient assistance programs. The Free Medicine Foundation enrollment center is helping people in need across the united States of America.

According to Randolph, there are hundreds of programs that offer free or nearly-free prescription drugs to those who qualify. Most all prescription drugs are on a free or low-cost assistance program. The biggest issue is letting people know that such programs actually exist and that the process of enrolling is not that difficult.

People interested in attempting to enroll in one of the many programs can simply call 1-573-996-3333 or log on to www.FreeMedicine.com.

The online enrollment is also easy, but will require the individual to have a list of drugs they are taking handy. Applicants can apply for as many drugs as needed, there is no limit. Include a $5 per prescription application processing fee (refundable if no assistance is received) indicating which drugs you need. And once enrolled, patients can continue to receive medication indefinitely as long as programs exist and patient continues to qualify.

For people facing tough prescription drug costs, the Free Medicine Foundation assistance program is a much needed effort. For more information and to access an application, visit www.FreeMedicine.com.


# # #

Press Contact: Cindy Randolph
Company Name: Free Medicine Foundation
Email: email protected from spam bots
Phone: 573-996-3333
Website: http://www.FreeMedicine.com

¶ 8:16 AM 0 comments

Children's Hospitals and Clinics of Minnesota Selects CDEX ValiMed(TM) to Implement Medication Validation Solution; ValiMed System Verifies Compounded Medications and Doses, and Validates Narcotic Returns

¶ 1:07 PM 0 comments